You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Dissolvable Materials for Photochemical Tissue Bonding

    SBC: Saxon Glass Technologies, Inc.            Topic: DHA21C001

    This PHASE II two-year proposal is designed to expand upon the knowledge gained already in the PHASE I research regarding the development of rapid bioresorbable glasses to bring us to the making of prototype stents which would be ready for testing in animals and humans. Motivated by the success of PHASE I research, wherein several bioresorbable glasses in the Na2O-K2O-CaO-B2O3-P2O5 have been devel ...

    STTR Phase II 2023 Department of DefenseDefense Health Agency
  2. Standard-issue Antimicrobial Combat Burn Gauze

    SBC: IFYBER LLC            Topic: DHA201D001

    The purpose of the continuation of this Direct-to-Phase II effort is to develop a field-expedient, antimicrobial, hydration-providing wound dressing for acute care of large burn wounds.

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  3. RAPID BIORESORBABLE Na2O-K2O-CaO-B2O3-P2O5 GLASSES

    SBC: Saxon Glass Technologies, Inc.            Topic: DHA21C001

    This Phase I proposal in research partnership with Rutgers the State University aims to explore the range of inorganic glass systems which are dissolvable in saline solutions at human body temperatures. Glasses in the Na2O-K2O-CaO-B2O3-P2O5 system with varying Na2O/K2O/CaO and B2O3/P2O5 will be melted. Glass substrates will be made which will be subjected to varying phase separation treatments in ...

    STTR Phase I 2022 Department of DefenseDefense Health Agency
  4. IRONCROWN: A Novel Medical Device for the Prehospital Diagnosis and Treatment of Traumatic Brain Injury

    SBC: WetWare BioSystems LLC            Topic: DHA211002

    Blast-related Traumatic Brain Injury (TBI) has plagued American servicemen since World War I. More than a century later, there remains no direct treatment for TBI, leaving at-risk populations vulnerable to life-long neurological damage and disability. WetWare BioSystems, in partnership with BlackBox Biometrics, has developed the revolutionary helmet-borne IRONCROWN medical device system, which is ...

    SBIR Phase I 2021 Department of DefenseDefense Health Agency
  5. A compact Energy Efficient Oxygen Generator for Deployed Military Medical Applications

    SBC: BETTERGY CORP.            Topic: DHA211009

    Oxygen is a necessary substance for human life and it is also, on the battlefield and in other emergency and medical situations, a life-saving substance. Oxygen for use in medical situations requires high purity and must be without contamination and the availability of a high concentration pure oxygen source is critically important in medical emergencies and on the battlefield. Additionally, at pr ...

    SBIR Phase I 2021 Department of DefenseDefense Health Agency
  6. Development of a Novel Cryostasis Cocktail and Protocol for High Subzero Banking of Human Organ

    SBC: SYLVATICA BIOTECH INC            Topic: DHP15013

    Initially, our technology and partnerships enable the preservation of good, but otherwise untransplanted, extended criteria donor livers as on‐demand, off‐the‐shelf, back‐up organs to save both civilian and service members patients lives27–32 where there are no options than often near certain death, and hence the FDA path also is attractive (see Transition Pla ...

    SBIR Phase II 2021 Department of DefenseDefense Health Agency
  7. Long-lasting Disposable Insecticidal / Repellent Fabric Barrier for Personal or Area Protection Against Biting Arthropods

    SBC: WIDDER BROS INC            Topic: DHP13003

    The Phase II Technical Objectives align with the project goals of developing an outdoor device for spatial protection in a defined, limited outdoor area. While existing work has proven out technology which is effective in indoor areas, the work has not b

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  8. Devices to Prevent and Treat Retained Hemothorax after Chest Injury

    SBC: SIM-VIVO LLC            Topic: DHP16011

    Blood in thechestcavity (hemothorax) as a result of injury remains a common and seriouschallengein military and civilian trauma management. The primary treatment of hemothoraxrequires a tubeto beinserted into the pleural space around thelung. Unfortunately, in about20% of thecases,significant amounts of blood,clot, and fibrin remain after initial drainage.Left untreated, thiscan lead to a permanen ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  9. Iron.Scan – a multiplexed point-of-care diagnostic system for diagnosing anemia and iron deficiency

    SBC: VITAME TECHNOLOGIES INC            Topic: DHP16005

    VitaMe Technologies Inc. (doing business as “VitaScan”) and Cornell University will develop the “Iron.Scan” - a point-of-care system for iron deficiency and anemia diagnosis in about 10 minutes from a finger stick of blood. The system comprises of (1) an

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  10. Rapid field testing of field water samples for total coliform and E. coli using isothermal amplification and unique micron-sized particles for cell capture and concentration

    SBC: IFYBER LLC            Topic: DHA17004

    iFyberLLC proposes to develop acoliform assay with differential detection of E.coliand total coliform that will circumvent thecurrent challenges with detectingthese organismsatalevel of1 CFU per100mLin less than 8 hours. The proposed assay targetsaresult in less than 8 hours by making use of novel microspherereagents forcaptureand concentration of thetargetcells,and couplingthesereagents with loop ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government